Literature DB >> 8755586

The recombination signals for adeno-associated virus site-specific integration.

R M Linden1, E Winocour, K I Berns.   

Abstract

The adeno-associated virus (AAV) genome integrates site specifically into a defined region of human chromosome 19 (termed AAVS1). Using a functional assay for AAV integration into AAVS1 DNA propagated as an episome, we obtained evidence that a 33-nucleotide AAVS1 DNA sequence contains the minimum signal required for targeted integration. The recombination signal comprises a DNA-binding motif for the AAV regulatory Rep protein [Rep binding site (RBS)] separated by an eight-nucleotide spacer from a sequence that can act as a substrate for Rep endonucleolytic activity [terminal resolution site (TRS)]. Mutations in either the AAVS1-encoded RBS or TRS elements abort targeted integration. Since both the RBS and TRS elements are present in the viral origin of replication and are required for AAV replication, targeted integration into chromosome 19 AAVS1 DNA may involve a replicative type of recombination that is discussed. An additional chromosome 19 element, which is responsible for DNA rearrangements in episomes propagating AAVS1 DNA, was identified and shown not to be required for AAV episomal integration, despite its location adjacent to the recombination signal.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755586      PMCID: PMC38858          DOI: 10.1073/pnas.93.15.7966

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES.

Authors:  R W ATCHISON; B C CASTO; W M HAMMON
Journal:  Science       Date:  1965-08-13       Impact factor: 47.728

2.  Complementation of adeno-associated virus growth with temperature-sensitive mutants of human adenovirus types 12 and 5.

Authors:  H Handa; K Shiroki; H Shimojo
Journal:  J Gen Virol       Date:  1975-11       Impact factor: 3.891

3.  Adeno-associated virus DNA replication: nonunit-length molecules.

Authors:  W W Hauswirth; K I Berns
Journal:  Virology       Date:  1979-02       Impact factor: 3.616

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Nucleotide sequence and organization of the adeno-associated virus 2 genome.

Authors:  A Srivastava; E W Lusby; K I Berns
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

7.  Detection of adeno-associated virus (AAV)-specific nucleotide sequences in DNA isolated from latently infected Detroit 6 cells.

Authors:  K I Berns; T C Pinkerton; G F Thomas; M D Hoggan
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

8.  Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells.

Authors:  A K Cheung; M D Hoggan; W W Hauswirth; K I Berns
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

9.  Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis.

Authors:  S E Straus; E D Sebring; J A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

10.  Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication.

Authors:  R M Buller; J E Janik; E D Sebring; J A Rose
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

View more
  107 in total

1.  Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins.

Authors:  J Wu; M D Davis; R A Owens
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 2.  Adeno-associated virus vectors and hematology.

Authors:  D W Russell; M A Kay
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

3.  Adeno-associated virus site-specifically integrates into a muscle-specific DNA region.

Authors:  N Dutheil; F Shi; T Dupressoir; R M Linden
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

4.  Kinetics of recombinant adeno-associated virus-mediated gene transfer.

Authors:  A K Malik; P E Monahan; D L Allen; B G Chen; R J Samulski; K Kurachi
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Linear transgene constructs lacking vector backbone sequences generate low-copy-number transgenic plants with simple integration patterns.

Authors:  X Fu; L T Duc; S Fontana; B B Bong; P Tinjuangjun; D Sudhakar; R M Twyman; P Christou; A Kohli
Journal:  Transgenic Res       Date:  2000-02       Impact factor: 2.788

6.  DNA sequence motifs which direct adeno-associated virus site-specific integration in a model system.

Authors:  P Meneses; K I Berns; E Winocour
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  The persistence of alien genomes.

Authors:  P Tattersall
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

8.  Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates.

Authors:  M D Davis; J Wu; R A Owens
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 9.  Designing antisense to inhibit the renin-angiotensin system.

Authors:  D Mohuczy; M I Phillips
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

10.  Cell Cycle-Dependent Expression of Adeno-Associated Virus 2 (AAV2) Rep in Coinfections with Herpes Simplex Virus 1 (HSV-1) Gives Rise to a Mosaic of Cells Replicating either AAV2 or HSV-1.

Authors:  Francesca D Franzoso; Michael Seyffert; Rebecca Vogel; Artur Yakimovich; Bruna de Andrade Pereira; Anita F Meier; Sereina O Sutter; Kurt Tobler; Bernd Vogt; Urs F Greber; Hildegard Büning; Mathias Ackermann; Cornel Fraefel
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.